Q1 Earnings Forecast for XENE Issued By HC Wainwright
Xenon Pharmaceuticals Inc. (NASDAQ:XENE – Free Report) – Equities researchers at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for shares of Xenon Pharmaceuticals in a research note issued to investors on Friday, February 28th. HC Wainwright analyst D. Tsao forecasts that the biopharmaceutical company will post earnings of ($1.32) per share […]
